Correlation Between Telix Pharmaceuticals and Platinum Asset

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Telix Pharmaceuticals and Platinum Asset at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Telix Pharmaceuticals and Platinum Asset into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Telix Pharmaceuticals and Platinum Asset Management, you can compare the effects of market volatilities on Telix Pharmaceuticals and Platinum Asset and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Telix Pharmaceuticals with a short position of Platinum Asset. Check out your portfolio center. Please also check ongoing floating volatility patterns of Telix Pharmaceuticals and Platinum Asset.

Diversification Opportunities for Telix Pharmaceuticals and Platinum Asset

-0.63
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Telix and Platinum is -0.63. Overlapping area represents the amount of risk that can be diversified away by holding Telix Pharmaceuticals and Platinum Asset Management in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Platinum Asset Management and Telix Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Telix Pharmaceuticals are associated (or correlated) with Platinum Asset. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Platinum Asset Management has no effect on the direction of Telix Pharmaceuticals i.e., Telix Pharmaceuticals and Platinum Asset go up and down completely randomly.

Pair Corralation between Telix Pharmaceuticals and Platinum Asset

Assuming the 90 days trading horizon Telix Pharmaceuticals is expected to generate 1.08 times more return on investment than Platinum Asset. However, Telix Pharmaceuticals is 1.08 times more volatile than Platinum Asset Management. It trades about 0.11 of its potential returns per unit of risk. Platinum Asset Management is currently generating about -0.04 per unit of risk. If you would invest  712.00  in Telix Pharmaceuticals on October 21, 2024 and sell it today you would earn a total of  1,947  from holding Telix Pharmaceuticals or generate 273.46% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Telix Pharmaceuticals  vs.  Platinum Asset Management

 Performance 
       Timeline  
Telix Pharmaceuticals 

Risk-Adjusted Performance

14 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Telix Pharmaceuticals are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Telix Pharmaceuticals unveiled solid returns over the last few months and may actually be approaching a breakup point.
Platinum Asset Management 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Platinum Asset Management has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's primary indicators remain comparatively stable which may send shares a bit higher in February 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Telix Pharmaceuticals and Platinum Asset Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Telix Pharmaceuticals and Platinum Asset

The main advantage of trading using opposite Telix Pharmaceuticals and Platinum Asset positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Telix Pharmaceuticals position performs unexpectedly, Platinum Asset can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Platinum Asset will offset losses from the drop in Platinum Asset's long position.
The idea behind Telix Pharmaceuticals and Platinum Asset Management pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

Other Complementary Tools

Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Fundamental Analysis
View fundamental data based on most recent published financial statements
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing